Bitcoin and Ether claw back some losses following a sharp sell-off, though derivatives data suggests traders remain cautious. The bounce coincides with a broader market relief rally spurred by U.S. fiscal developments.
The industrial toolmaker reported flat year-over-year sales of $3.68 billion for Q4 2025, missing analyst estimates, though adjusted earnings per share of $1.41 came in nearly 10% above forecasts. The mixed results highlight ongoing challenges in a dynamic market.
Novo Nordisk's stock tumbled sharply after the Danish pharmaceutical giant issued a weaker-than-expected forecast for 2026, citing pricing deals and competitive threats to its blockbuster weight-loss drugs.
Human Rights Watch's latest annual assessment warns of a deepening crisis for international human rights norms, citing concerted pressure from major powers and a rising tide of authoritarian governance affecting billions worldwide.
Chancellor Friedrich Merz embarks on a pivotal three-nation Gulf tour, signaling Berlin's strategic push to diversify trade and energy partnerships amid global realignment, as both Germany and the Gulf monarchies seek to reduce mutual dependencies.
Myanmar’s military-aligned party has secured a sweeping victory in a tightly controlled election, official results confirm, as the junta chief signs into law a new advisory body that could cement the army’s influence behind the scenes of any new civilian government.
The search for Savannah Guthrie's 84-year-old mother, Nancy, enters its fourth day with the disturbing emergence of purported ransom notes sent to media outlets, as authorities investigate signs of a forced entry at her Tucson home.
Long-term investors in Integra LifeSciences Holdings have seen their holdings decimated, with the stock's dramatic decline raising questions about the medical device maker's turnaround prospects and broader sector challenges.
UBS capped a transformative year with a 56% jump in Q4 profit, pushing group invested assets past the $7 trillion milestone for the first time, as its integration of Credit Suisse nears completion.
GSK's annual net profit more than doubled in 2025, fueled by robust sales of HIV, respiratory, and oncology medicines. The results signal a strong recovery for the pharma giant after settling costly U.S. lawsuits related to its discontinued heartburn drug Zantac.
CoreWeave's 2025 journey from private AI infrastructure provider to a publicly traded, system-critical force clarified its investment thesis. With a massive $55B backlog, the focus now shifts from demand to execution.
The New York Times Company (NYSE: NYT) reported fourth-quarter revenue of $802.3 million, a 10.4% year-over-year increase that surpassed analyst expectations. While adjusted earnings per share met consensus, the results highlight both the strength of its digital transition and ongoing challenges in monetizing its growing subscriber base.
Bolstered by strong growth in digital subscriptions and advertising, The New York Times reported quarterly revenue of $802.3 million, exceeding forecasts and marking another step toward its ambitious 2027 subscriber target.
Johnson Controls International (NYSE: JCI) reported fourth-quarter results that exceeded analyst expectations, with revenue climbing 6.8% year-over-year to $5.80 billion. Adjusted earnings per share of $0.89 also topped estimates, sending the stock sharply higher.
A surge in late self-assessment payments has resulted in a £325 million windfall for HMRC in penalties and interest, with experts warning the tax authority shows no sign of leniency as unpaid liabilities mount.
Ahold Delhaize's latest fair value estimate sees a marginal adjustment, yet the gap between bullish and bearish analyst targets remains wide. Behind the numbers, subtle changes in discount rates and growth forecasts signal an ongoing debate over the retail giant's resilience in a challenging market.
WeRide's stock has plummeted 48% over the past year, leaving investors to grapple with a stark contradiction: a DCF model suggests massive undervaluation, while its sky-high P/S ratio screams overvaluation. We examine the numbers, the narrative, and what it means for the autonomous driving pioneer's future.
As the second year of the second Trump administration unfolds, grocery prices remain elevated, shaped by a complex mix of enduring trade policies, climate disruptions, and structural labor costs. Experts warn of a two-track market where some relief is possible, but core inflationary pressures are here to stay.
Mondelez International merges its financial and operational command under longtime CFO Luca Zaramella, signaling a strategic push for tighter alignment between profit goals and on-the-ground execution amid market pressures.
Facing mounting pressure from rivals and U.S. pricing policies, Novo Nordisk warns of its first annual sales decline since 2017, sending its stock tumbling and forcing a strategic overhaul.
